These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6538252)

  • 1. Interaction of fibrinolytic activity between the tracheobronchial secretion and circulating blood of rats.
    Kosugi T; Takagi I; Kinjo K; Sueno K; Noda K; Sumi H; Mihara H
    Laryngoscope; 1984 Mar; 94(3):386-90. PubMed ID: 6538252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic enzyme in tracheobronchial secretion of rats: existence of plasminogen activator.
    Kosugi T; Morimitsu T; Matsuo O; Mihara H
    Laryngoscope; 1980 Jun; 90(6 Pt 1):1045-51. PubMed ID: 6991840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ultrasonic nebulization of Miraclid on the proteolytic activity in tracheobronchial secretions of rats.
    Kosugi T; Nakamura M; Noguchi S; Huang GW
    Laryngoscope; 1989 Dec; 99(12):1281-5. PubMed ID: 2601543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
    Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
    Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous and plasma fibrinolytic activity in systemic sclerosis. Evidence of normal plasminogen activation.
    Matucci-Cerinic M; Lotti T; Lombardi A; Pignone A; Iannone F; Beneforti E; Cinotti S; Morfini M; Caignoni M
    Int J Dermatol; 1990 Nov; 29(9):644-8. PubMed ID: 2125582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The stimulation of fibrinolysis during cholinergic vasodilating reactions].
    Bashkov GV; Sergeev IIu; Medvedeva NA; Makarov VA
    Fiziol Zh (1978); 1990; 36(4):3-8. PubMed ID: 2146171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide (VIP) stimulates fibrinolytic system in the rat.
    Hagiwara M; Hongo K; Morikawa T
    Jpn J Pharmacol; 1990 Sep; 54(1):86-8. PubMed ID: 2273652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of human plasminogen activator and of a fraction of fibrinolytically active plasma enriched with this enzyme].
    Plastonova TK; Petrenko OA
    Vopr Med Khim; 1979; 25(3):302-7. PubMed ID: 156462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluidity of cadaveric blood after sudden death: Part II. Mechanism of release of plasminogen activator from blood vessels.
    Takeichi S; Wakasugi C; Shikata I
    Am J Forensic Med Pathol; 1985 Mar; 6(1):25-9. PubMed ID: 4039106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of in vitro and in vivo decreased fibrinolytic activity caused by dexamethasone.
    van Giezen JJ; Jansen JW
    Ann N Y Acad Sci; 1992 Dec; 667():199-201. PubMed ID: 1309037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage.
    Roos YB; Levi M; Carroll TA; Beenen LF; Vermeulen M
    Stroke; 2001 Aug; 32(8):1860-2. PubMed ID: 11486117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of high doses of tissue plasminogen activator on the hemostatic and fibrinolytic systems].
    Liutova LV; Shimonaeva EE; Andreenko GV
    Kardiologiia; 1983 Aug; 23(8):95-8. PubMed ID: 6684710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the fibrinolytic system.
    Robison AK; Collen D
    Cardiol Clin; 1987 Feb; 5(1):13-9. PubMed ID: 3103919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue-type) plasminogen activator.
    Allen RA; Kluft C; Brommer EJ
    Eur J Clin Invest; 1984 Oct; 14(5):354-61. PubMed ID: 6437833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.